logo
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
logo
CONTACT US
CALL US
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us

Home » FDA Safety Announcement Concerning Actos Use and Bladder Cancer Risk

FDA Safety Announcement Concerning Actos Use and Bladder Cancer Risk

The U.S. Food and Drug Administration, (FDA) released a safety announcement on September 17, 2010, that it is reviewing a 10-year epidemiological study to evaluate whether Actos (pioglitazone), is associated with an increased risk of bladder cancer. Actos, is a drug manufactured by Takeda to help control blood sugar levels in adults diagnosed with Type II diabetes mellitus. While the FDA has not made any conclusions about the study which is currently in its fifth year, it has indicated a statistical significance of increased bladder cancer risk in patients with prolonged use and/or higher dosage of Actos.

If you or a loved one is experiencing any side effects after using Actos or another drug to treat Type II diabetes, please contact Cohen & Malad, LLP to speak with one of our experienced product liability/personal injury attorneys to discuss your legal options and help you seek the compensation you deserve.

One Indiana Square Suite 1400
Indianapolis, Indiana 46204

Copyright ©  Cohen & Malad, LLP. All rights reserved.

Disclaimer  |  Privacy Policy

 

Schedule a free consultation Today
  • This field is for validation purposes and should be left unchanged.

Schedule a free consultation Today

  • This field is for validation purposes and should be left unchanged.

ALERTS

Former Speedway High School Teacher and Coach Faces Child Seduction Charges

The Marion County Prosecutor has charged Tyler Carmichael, a former teacher at Speedway High School and track .. Read More

SEE ALL ALERTS

In the News

Indiana Legal Services and Indiana State Bar Foundation Receive $90,000 donation from Cohen & Malad, LLP Class Action United Way of Central Indiana’s Center for Working Families Receives $32,000 from Cohen & Malad, LLP Settlement Funds Indianapolis Neighborhood Housing Partnership Receives $32,000 from Cohen & Malad, LLP Settlement Funds
READ OUR NEWS